← Back to headlines
ImmunityBio Reports Q4 GAAP EPS of -$0.06 and Revenue of $38.2M
ImmunityBio announced its GAAP earnings per share of -$0.06 and reported revenue of $38.2 million for the latest quarter.
23 Feb, 13:06 — 23 Feb, 13:06
ℹOnly 1 source covers this story
Read at source (1 outlet)
Related Stories
Key Events This Week: PPI, Iran Talks, Nvidia Earnings, Fed Speakers Galore And State Of The Union
2m ago
Primanti Bros. closes two Central Pennsylvania restaurants
2m ago
RERA Disposal Rates Conceal Poor Homebuyer Recovery, Says FPCE
6m ago
Memphis Baker Chloe Sexton Sued Over Company Name 'Chloe's Giant Cookies'
6m ago